Intrapartum Chemoprophylaxis for GBS

There has been much discussion about the best approach to preventing neonatal Group B Streptococcal (GBS) infection. While there is still controversy about this issue, both the U.S. Centers for Disease Control (CDC) and the Society of Obstetricians & Gynaecologists of Canada (SOGC) recommend universal screening at 35-37 weeks gestation and treatment based on culture results or risk factors if the culture results are not known.

Date Revised: 
July, 2005